Hepatitis B: all 1,662 studies
Page 11 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B VaccineCompletedNCT02692170Phase 1/2
- Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.CompletedNCT02689245Not applicable
- Chronic Hepatitis B and C Recall Northern HollandStatus unknownNCT02687061
- A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
- Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseWithdrawnNCT02658786
- Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected PatientsCompletedNCT02646189Phase 1/2
- Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected PatientsCompletedNCT02646163Phase 1/2
- Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)IdesStatus unknownNCT02644538Phase 4
- Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue TherapyCompletedNCT02631096Phase 2
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
- Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy VolunteersCompletedNCT02612506Phase 1
- Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeCompletedNCT02610348Not applicable
- Hepatitis B in Cystic Fibrosis and Latent Tuberculosis RespectivelyWithdrawnNCT02605538Not applicable
- New Strategy Study of Functional Cure of Chronic Hepatitis BStatus unknownNCT02605252Not applicable
- A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)CompletedNCT02604823Phase 4
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B PatientsTerminatedNCT02604355Phase 1
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedNCT02598063Phase 4
- Thousand Asian American StudyCompletedNCT02596438
- Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC TherapyCompletedNCT02594293Phase 4
- Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir TherapyStatus unknownNCT02589652
- Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® TabletCompletedNCT02589457Phase 1
- Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B PatientsStatus unknownNCT02588937Phase 4
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)CompletedNCT02584543Phase 4
- Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue TherapyCompletedNCT02582333
- Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B PatientsStatus unknownNCT02581033Not applicable
- A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)CompletedNCT02570191Phase 4
- A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsCompletedNCT02569372Phase 1
- Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-FranceCompletedNCT02566148
- REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B InfectionCompletedNCT02565719Phase 2
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric StudyCompletedNCT02548325
- Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis BCompletedNCT02533544
- Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis BStatus unknownNCT02532413Phase 4
- Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
- Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus InfectionCompletedNCT02511743
- Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the PregnancyStatus unknownNCT02510963Not applicable
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedNCT02499562Phase 2
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownNCT02482272Phase 4
- Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive PatientsStatus unknownNCT02474316Phase 4
- Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
- Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B VaccineCompletedNCT02445703Phase 4
- A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity StudyCompletedNCT02444611Not applicable
- Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong KongCompletedNCT02443233
- A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesCompletedNCT02434848Phase 2/3
- Comparison of Immunization Quality Improvement Dissemination StudyCompletedNCT02432430Not applicable
- Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B SubjectsCompletedNCT02431312Phase 1
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCompletedNCT02428491Phase 3
- Safety and Tolerability of TG1050: A Dose-finding StudyCompletedNCT02428400Phase 1
- Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver TransplantationStatus unknownNCT02417207Phase 4
- Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon TherapyStatus unknownNCT02412592
- The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor InjectionStatus unknownNCT02412319Phase 4
- Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in TaiwanCompletedNCT02402699
- Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
- A Hepatitis B With Hepatic Steatosis StudyStatus unknownNCT02392598
- A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT02391805Phase 2
- Validity of Elastography During PregnancySuspendedNCT02391467
- Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B PatientsStatus unknownNCT02387684
- Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT02387463
- Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02368288Phase 4
- Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian ImmigrantsCompletedNCT02366286
- Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis BStatus unknownNCT02366247Phase 3
- Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis BCompletedNCT02366208Phase 2
- Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02365402Phase 4
- The Influence of Short-term Starvation on Hepatitis B Virus LoadStatus unknownNCT02364661Not applicable
- Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) AnaloguesStatus unknownNCT02362490Phase 4
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B PatientsCompletedNCT02360592Phase 4
- Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infectionCompletedNCT02355951Not applicable
- Study of ARC-520 in Patient With Chronic Hepatitis B VirusWithdrawnNCT02349126Phase 2
- Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon TreatmentStatus unknownNCT02348502
- Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East AfricaActive, not recruitingNCT02344498
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
- Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsStatus unknownNCT02337127Phase 4
- Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon TreatmentStatus unknownNCT02336399
- A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BCompletedNCT02332473Phase 2
- RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic FailureStatus unknownNCT02331745Phase 4
- Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive PatientsStatus unknownNCT02327715Phase 4
- Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B PatientsStatus unknownNCT02327702Phase 4
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
- Emtricitabine for Naive Child Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327676Phase 4
- Emtricitabine for Naive Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327663Phase 4
- A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)Status unknownNCT02327416Phase 3
- This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of AgeCompletedNCT02324218
- Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B VaccinationCompletedNCT02323308
- Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in UgandaCompletedNCT02316444Phase 4
- ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis BCompletedNCT02313649
- Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
- A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant RecipientsCompletedNCT02304315Phase 2
- The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of ChildrenStatus unknownNCT02301650
- Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult VolunteersCompletedNCT02300688Phase 1
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsWithdrawnNCT02289300Phase 2
- Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis BTerminatedNCT02288208Phase 1
- Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
- Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative ResectionStatus unknownNCT02281266Phase 4
- Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney FunctionStatus unknownNCT02267473
- Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis BCompletedNCT02263755
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B InfectionTerminatedNCT02258581
- Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 WeeksStatus unknownNCT02257645